Search
Spyre Therapeutics Inc
SYREAdd to Watchlist
98.330USD
-3.170-3.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.54BMarket Cap
LossP/E TTM
SYRE Financials
See Spyre Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Spyre Therapeutics Inc Earnings Date
Latest Release
May 5, 2026
EPS / Forecast
-0.88/-0.67
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.42
45.22%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its current assets were 777.78M, with a year-on-year change of 27.82.
What are the total assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total assets of Spyre Therapeutics Inc were 777.78M, with a year-on-year change of 27.82.
What are the total liabilities of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total liabilities of Spyre Therapeutics Inc were 62.55M, with a year-on-year change of -31.03.
What is the total equity of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total equity of Spyre Therapeutics Inc was 715.24M, with a year-on-year change of 38.13.
What is the net operating income of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net operating income of Spyre Therapeutics Inc was -219.56M, with a year-on-year change of -5.27.
What is the net investment of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net investment of Spyre Therapeutics Inc was -143.47M, with a year-on-year change of 59.39.
What is the net financing of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net financing of Spyre Therapeutics Inc was 309.02M, with a year-on-year change of -24.79.
What is the Earnings Per Share (EPS) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.42, with a year-on-year change of 45.22.
What is the net income of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net income was -155.20M, with a year-on-year change of 25.39.
What is the Return on Equity (ROE) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -33.69, with a year-on-year change of 70.76.
What is the Return on Assets (ROA) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -22.39, with a year-on-year change of 48.85.
What is the operating profit of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its operating profit was -219.56M, with a year-on-year change of -5.27.